ARCHIVES

Study: Keytruda Improves PFS In Ipilimumab-Refactory Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO Recommends Discussing Pharmacological Prevention

July 26, 2013

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

Funding Opportunities (12-page issue).

May 16, 2003

NIH News: Varmus Presents “Modest Proposal for a Simpler NIH”

August 6, 1999

Public Health Service: Blumenthal Declines White House Job

November 14, 1997

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980